Erosive gastroduodenitis. Gastroduodenitis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Erosive gastroduodenitis in endoscopy Negative Helicobacter pylori Test Written informed consent
Exclusion criteria
Exclusion criteria: pregnancy and lactation cardiovascular disease epilepsy anticoagulant medications use of a research drug in the past 30 day any factor to reduce patient compliance and tolerance, such as alcohol and drug abuse The existence of a severe illness that make performing endoscopy for them dangerous severe bleeding Coagulation Disorders Zollinger Ellison syndrome lung disease Malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of gastrointestinal symptoms. Timepoint: At the beginning of the study (before the intervention) and at the end of the study (28 days after the intervention). Method of measurement: A questionnaire derived from ROME III and Visual Analogue Scale questionnaire.;Frequency of symptoms in the week. Timepoint: At the beginning of the study (before the intervention) and at the end of the study (28 days after the intervention). Method of measurement: A questionnaire derived from ROME III. | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment Adverse reaction. Timepoint: End of the study. Method of measurement: Ask from patient.;Treatment satisfaction. Timepoint: End of the study. Method of measurement: Questionnair. | — |
Countries
Iran (Islamic Republic of)
Contacts
Islamic Azad University